Overview
Citicoline is a donor of choline in biosynthesis of choline-containing phosphoglycerides. It has been investigated for the treatment, supportive care, and diagnosis of Mania, Stroke, Hypomania, Cocaine Abuse, and Bipolar Disorder, among others.
Indication
主要用于急性颅脑外伤和脑手术后的意识障碍，以及脑卒中而致偏瘫的患者；也用于耳鸣及神经性耳聋、急性中毒、感染、大面积脑梗死所致的昏迷和意识障碍、帕金森病、急性胰腺炎；对缺血性脑血管病和血管性痴呆也有一定疗效,但对颅内出血引起的意识障碍效果较差。
Associated Conditions
- Degenerative Brain Disorder
- Parkinsonian Syndromes
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/07/26 | Phase 1 | Recruiting | Armed Forces Hospital, Pakistan | ||
2024/01/18 | Phase 3 | Recruiting | |||
2023/05/31 | Phase 1 | Active, not recruiting | |||
2023/05/23 | Phase 2 | Recruiting | |||
2023/02/02 | Phase 3 | Recruiting | Omikron Italia S.r.l. | ||
2021/12/13 | Phase 3 | UNKNOWN | |||
2021/03/17 | Phase 2 | UNKNOWN | Dinara Zhumanbayeva | ||
2019/07/01 | Not Applicable | Completed | Istituto di Ricerca Neuroftalmologia S.r.l. | ||
2019/05/29 | Phase 3 | Recruiting | Sherief Abd-Elsalam | ||
2019/05/14 | Phase 3 | Recruiting | Sherief Abd-Elsalam |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| SOMAZINA ORAL SOLUTION 100MG/ML | N/A | N/A | N/A | 5/10/2017 | |
| SOMAZINA ORAL SOLUTION 1000MG IN 10ML SACHET | N/A | N/A | N/A | 12/1/2021 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| SOMAZINA 500 mg SOLUCION INYECTABLE | 54390 | SOLUCIÓN INYECTABLE | Medicamento Sujeto A Prescripción Médica | Commercialized | |
| SOMAZINA 1g SOLUCION INYECTABLE | 54389 | SOLUCIÓN INYECTABLE | Medicamento Sujeto A Prescripción Médica | Commercialized | |
| SOMAZINA 100 mg/ml SOLUCION ORAL | 53168 | SOLUCIÓN ORAL | Medicamento Sujeto A Prescripción Médica | Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.